title: Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma.
authors.forename: Jasmine
authors.initials: J
authors.lastname: Zain
authors.forename: Arnold
authors.initials: A
authors.lastname: Rotter
authors.forename: Lawrence
authors.initials: L
authors.lastname: Weiss
authors.forename: Stephen
authors.initials: S
authors.lastname: Forman
authors.forename: Mark H
authors.initials: MH
authors.lastname: Kirschbaum
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D016393:Lymphoma, B-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008875:Middle Aged; D049268:Positron-Emission Tomography; D012008:Recurrence; D012074:Remission Induction; D017211:Treatment Failure; D014635:Valproic Acid / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D019788:Fluorodeoxyglucose F18; D014635:Valproic Acid